President Trump Issues Executive Orders to Lower Drug Prices

On July 24, 2020, President Donald Trump issued the following series of executive orders in an effort to lower drug prices:

President Trump also announced a fourth executive order intended to ensure that the United States pays the lowest price available in economically comparable countries for Medicare Part B drugs. However, the order's implementation is delayed until Aug. 25, 2020, to give pharmaceutical executives a chance to propose an alternative.


An executive order is a broad policy directive that is used to establish how laws will be enforced by the administration. It does not include specific guidance regarding any particular legal requirement or provision, and does not change any existing regulations. As a result, the specific impact of these executive orders is largely unclear until the administration can begin implementing these changes.


Important Dates


July 24, 2020: President Trump signed four executive orders intended to lower drug prices. The specific impact of these executive orders is largely unclear until the administration can begin implementing these changes.


Aug. 25, 2020: Implementation of the fourth executive order is delayed until Aug. 25, 2020, to allow pharmaceutical executives a chance to propose an alternative.

This Legal Update is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel for legal advice.

  • Facebook Social Icon
  • LinkedIn Social Icon

1954 Greenspring Drive, Suite 640

Timonium, MD 21093

Privacy Policy

©2018 Allegeant | All content on this site is copyrighted by Allegeant LLC.

Total-Focus-Logo (002).png